Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin Treatment

Abroad (travel likely)RecruitingPHASE1

Conditions

Staphylococcal Aureus Infection · Microbial Colonization · Pediatric Infection · S. Aureus Colonization · Microbial Transplant

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Johns Hopkins University, Baltimore, Maryland, United States
Contact: Study coordinator (Danielle Koontz, Research Manager) · dkoontz1@jhmi.edu · 443-287-9040
Contact: Principal Investigator (Aaron M Milstone, MD)

Study leads

Aaron M Milstone, MD
Principal Investigator
Johns Hopkins University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Comparing Single Versus Repeat NMT on the Diversity of the Neonatal Nasal Microbiome

Staphylococcus Aureus · Microbial Colonization · Neonatal Infection

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States

First-in-man Single-dose and Multiple Dose Study to Evaluate the Safety, Tolerability and Efficacy ofHY-133

Staphylococcus Aureus

Abroad (travel likely)RecruitingPHASE1

Tübingen, Germany · Tübingen, Germany

A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)

Staphylococcus Aureus

Abroad (travel likely)RecruitingPHASE1, PHASE2

Huntsville, United States · Chula Vista, United States

Linezolid Plus Standard of Care

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Abroad (travel likely)Recruiting

Aarau, Switzerland · Basel, Switzerland